The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

INMEVA, suspension for injection

Laboratorios Hipra S.A.VPA10846/018/001

Main Information

Trade NameINMEVA, suspension for injection
Active SubstancesChlamydophila abortus strain A22 inactivated
Salmonella enterica subsp. enterica serovar Abortusovis strain Sao
Dosage FormSuspension for injection
Licence HolderLaboratorios Hipra S.A.
License Holder AddressAvda. La Selva 135
17170 - Amer (Girona)
Licence NumberVPA10846/018/001

Group Information

ATC CodeQI04AB Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued14/06/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back